Cargando…
Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis
BACKGROUND: The development of a novel tuberculosis vaccine is a leading global health priority. SRL172, an inactivated, whole-cell mycobacterial vaccine, was safe, immunogenic and reduced the incidence of culture-confirmed tuberculosis in a phase III trial in HIV-infected and BCG immunized adults i...
Autores principales: | Lahey, Timothy, Laddy, Dominick, Hill, Krystal, Schaeffer, Jacqueline, Hogg, Alison, Keeble, James, Dagg, Belinda, Ho, Mei Mei, Arbeit, Robert D., von Reyn, C. Fordham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173179/ https://www.ncbi.nlm.nih.gov/pubmed/27997597 http://dx.doi.org/10.1371/journal.pone.0168521 |
Ejemplares similares
-
Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901
por: von Reyn, C. Fordham, et al.
Publicado: (2017) -
CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial
por: Masonou, Tereza, et al.
Publicado: (2019) -
Efficacy and immunogenicity of different BCG doses in BALB/c and CB6F1 mice when challenged with H37Rv or Beijing HN878
por: Khatri, Bhagwati, et al.
Publicado: (2021) -
Isolation of Mycobacterium avium from Potable Water in Homes and Institutions of Patients with HIV Infection in Finland and the United States
por: Ristola, Matti, et al.
Publicado: (2015) -
Altruism, Scepticism, and collective decision-making in foreign-born U.S. residents in a tuberculosis vaccine trial
por: Craig, Sienna R., et al.
Publicado: (2018)